| Serial Number | 79320671 |
| Word Mark | SCIRENT CLINICAL RESEARCH AND SCIENCE |
| Filing Date | Wednesday, April 21, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, October 11, 2022 |
| Registration Number | 6868383 |
| Registration Date | Tuesday, October 11, 2022 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, July 26, 2022 |
| Description of Mark | The sign consists of the word SCIRENT, in Latin capital letters, in black. Below the word SCIRENT, there are four words - Clinical Research and Science, in Latin letters, in blue. In the upper right corner, above the word SCIRENT there is a circle in different shades of green and blue (light green, dark green, light blue, dark blue) whose center is painted in white |
| Indication of Colors claimed | The color(s) white, black, blue and green is/are claimed as a feature of the mark. |
| Disclaimer with Predetermined Text | "CLINICAL RESEARCH AND SCIENCE" |
| Goods and Services | Medical and scientific research and data analysis services; implementation and analysis of clinical trials in the field of medicines, medical devices, biotechnology and natural sciences; development of protocols, scientific consultation, and preparation of reports with respect to medical research; research center project management; local and global clinical trial project management; pharmaceutical drug development services, development of clinical trial methodologies; consultancy services in the field of pharmaceutical clinical trials; extensive clinical research services for others; electronic storage services for clinical trial data; biostatic analysis; services provided by consultants with respect to research in the field of environmental protection, preclinical research and evaluation of pharmaceutical product development; conducting clinical trials for others in the nature of scientific research, especially the correction of clinical trials and defective records; clinical trial services in the nature of strategic management of clinical research portfolios and follow-up of biological monitoring; providing information in the field of natural sciences and scientific research to physicians and other health professionals, to patients and to medical, pharmaceutical and biotechnological companies; providing technical drafting services for complaints and/or disputes in the field of medical research and clinical studies; consultation services in the field of clinical research under contract and product development under contact; design and development of computer hardware as well as consultation services relating thereto for others; creating websites featuring blogs on medical and pharmaceutical information relating to chronic conditions and diseases; creating and maintaining Internet websites for patients and registered care providers to form virtual communities and to engage in the field of health; design and development of an interactive software for use in the communication and dissemination of medical and pharmaceutical information |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 27, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | SCIRENT CLINICAL RESEARCH AND SCIENCE D.O.O. BEOGRAD-VRACAR |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | RS |
| Party Name | SCIRENT CLINICAL RESEARCH AND SCIENCE D.O.O. BEOGRAD-VRACAR |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | RS |
| Party Name | SCIRENT CLINICAL RESEARCH AND SCIENCE D.O.O. BEOGRAD-VRACAR |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | RS |
| Event Date | Event Description |
| Tuesday, March 21, 2023 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Monday, January 30, 2023 | GENERIC MADRID TRANSACTION SENT TO IB |
| Monday, January 30, 2023 | GENERIC MADRID TRANSACTION CREATED |
| Wednesday, January 11, 2023 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, October 11, 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, October 11, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, July 26, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 26, 2022 | PUBLISHED FOR OPPOSITION |
| Monday, July 25, 2022 | NOTIFICATION PROCESSED BY IB |
| Thursday, July 7, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, July 6, 2022 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, July 6, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, June 22, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Saturday, June 4, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, June 4, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, June 4, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sunday, February 6, 2022 | REFUSAL PROCESSED BY IB |
| Tuesday, January 18, 2022 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Tuesday, January 18, 2022 | REFUSAL PROCESSED BY MPU |
| Thursday, December 23, 2021 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Wednesday, December 22, 2021 | NON-FINAL ACTION WRITTEN |
| Wednesday, December 15, 2021 | ASSIGNED TO EXAMINER |
| Friday, October 1, 2021 | APPLICATION FILING RECEIPT MAILED |
| Monday, September 27, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, September 16, 2021 | SN ASSIGNED FOR SECT 66A APPL FROM IB |